Loomis, Sayles & Company
REPL icon

Loomis, Sayles & Company’s Replimune Group REPL Stock Holding History

Loomis, Sayles & Company’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,290,450
Closed -$22.1M – 1032
2023
Q3 		$22.1M Buy
1,290,450
+103,223
+9% +$2.03M 0.04% 233
2023
Q2 		$27.6M Buy
1,187,227
+228,561
+24% +$4.47M 0.04% 207
2023
Q1 		$16.9M Buy
+958,666
New +$22.8M 0.03% 255
2022
Q1 		– Sell
-1,108,869
Closed -$30.1M – 1043
2021
Q4 		$30.1M Sell
1,108,869
-27,197
-2% -$813K 0.04% 251
2021
Q3 		$33.7M Buy
1,136,066
+143,473
+14% +$4.66M 0.04% 231
2021
Q2 		$38.1M Buy
992,593
+215,411
+28% +$7.37M 0.05% 215
2021
Q1 		$23.7M Buy
+777,182
New +$29.1M 0.03% 268

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company's REPL Position: Q4 2023 in Review

Loomis, Sayles & Company sold out of Replimune Group (REPL) in Q4 2023, closing a stake of 1,290,450 shares — an estimated $22.1M sold.

Loomis, Sayles & Company first reported a position in REPL in Q1 2021 and held it in 7 quarters. The position peaked at $38.1M in Q2 2021. 140 funds tracked by Wall St. Rank hold REPL as of Q4 2023.

  • Loomis, Sayles & Company reported no remaining Replimune Group position as of Q4 2023 after selling out during the quarter.
  • Loomis, Sayles & Company sold 1,290,450 Replimune Group shares in Q4 2023, an estimated $22.1M.
  • Loomis, Sayles & Company first reported a position in Replimune Group in Q1 2021 and held it in 7 quarters.
  • Loomis, Sayles & Company's Replimune Group position peaked at $38.1M in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Replimune Group as of Q4 2023.

Based on Loomis, Sayles & Company's 13F filing for Q4 2023, filed 13 Feb 2024.